Editorial: Direct Acting Antivirals - Not the Be-All and End-All in HIV/HCV Co-Infection. Authors' Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.13903
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Good News to Patients With Thalassaemia-HCV Clearance Made Easy With Direct Acting Antivirals. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Survival of HIV/HCV Co-Infected Patients Before Introduction of HCV Direct Acting Antivirals (DAA)

Scientific Reports
Multidisciplinary
2019English

Letter: HBV/HCV Coinfection in the Era of Direct-Acting Antivirals

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank

PLoS ONE
Multidisciplinary
2016English

Editorial: Direct-Acting Antivirals Significantly Improve Quality of Life in Patients With Hepatitis C Virus Infection

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Diabetes in HIV-infected Patients-Do Not Blame the Usual Suspect! Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Metabolic Surgery: One Size Fits All? – Authors' Reply

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Imaging Findings of Hepatocellular Carcinoma That Developed After HCV Eradication With Direct-Acting Antivirals

Acta Hepatologica Japonica
Hepatology
2019English

Treatment Efficacy of All-Oral Combinations of Direct-Acting Antivirals in Chronic Hepatitis C Patients With NS5A-P32 Deletion

Acta Hepatologica Japonica
Hepatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy